226 related articles for article (PubMed ID: 33357362)
1. Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases.
Wang Y; Yu H; He J
Discov Med; 2020; 30(159):49-56. PubMed ID: 33357362
[TBL] [Abstract][Full Text] [Related]
2. Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus.
Reiss AB
Curr Rheumatol Rep; 2009 Aug; 11(4):255-60. PubMed ID: 19691928
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia promotes germinal center reactions via IL-27.
Ryu H; Chung Y
BMB Rep; 2018 Aug; 51(8):371-372. PubMed ID: 30037367
[TBL] [Abstract][Full Text] [Related]
4. High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic Strategy.
Kim SY; Yu M; Morin EE; Kang J; Kaplan MJ; Schwendeman A
Arthritis Rheumatol; 2020 Jan; 72(1):20-30. PubMed ID: 31350818
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia in systemic lupus erythematosus.
Szabó MZ; Szodoray P; Kiss E
Immunol Res; 2017 Apr; 65(2):543-550. PubMed ID: 28168401
[TBL] [Abstract][Full Text] [Related]
6. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice.
Braun Na; Wade NS; Wakeland EK; Major AS
Lupus; 2008 Dec; 17(12):1070-8. PubMed ID: 19029274
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus.
Atta AM; Silva JPCG; Santiago MB; Oliveira IS; Oliveira RC; Sousa Atta MLB
Clin Rheumatol; 2018 Jun; 37(6):1539-1546. PubMed ID: 29516281
[TBL] [Abstract][Full Text] [Related]
8. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
Abou-Raya A; Abou-Raya S
Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
[TBL] [Abstract][Full Text] [Related]
9. Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus.
Fesmire J; Wolfson-Reichlin M; Reichlin M
Rev Bras Reumatol; 2010; 50(5):539-51. PubMed ID: 21125190
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.
McMahon M; Hahn BH
Curr Opin Immunol; 2007 Dec; 19(6):633-9. PubMed ID: 18083018
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus.
Huang S; Zhang Z; Cui Y; Yao G; Ma X; Zhang H
Clin Rheumatol; 2023 Jun; 42(6):1565-1572. PubMed ID: 36790644
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations.
Ortiz TT; Terreri MT; Caetano M; Souza FS; D'Almeida V; Sarni RO; Hilário MO
Ann Nutr Metab; 2013; 63(1-2):77-82. PubMed ID: 23942034
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus].
Liu L; Zhang T; Ye Y; Zhang S; Chen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096
[TBL] [Abstract][Full Text] [Related]
15. The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity.
Wade NS; Major AS
Thromb Haemost; 2011 Nov; 106(5):849-57. PubMed ID: 21979131
[TBL] [Abstract][Full Text] [Related]
16. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
Ardoin SP; Sandborg C; Schanberg LE
Lupus; 2007; 16(8):618-26. PubMed ID: 17711898
[TBL] [Abstract][Full Text] [Related]
17. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus.
Tyrrell PN; Beyene J; Benseler SM; Sarkissian T; Silverman ED
J Rheumatol; 2007 Oct; 34(10):2112-9. PubMed ID: 17787042
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity, oxidized LDL and cardiovascular disease.
Frostegård J
Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein functionality in systemic lupus erythematosus.
Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
Hahn BH; McMahon M
Lupus; 2008 May; 17(5):368-70. PubMed ID: 18490409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
